Navigation and service

BIENNIAL REPORT 2019/2020

Welcome

Welcome

Research

Research

International

International

Regulation

Regulation

Organisation

Organisation

Data & Facts

Data & Facts

25.11.2020 back forward

COVID-19 Peptide Vaccine: First Clinical Trial

Picture of SARS-Cov-2 Coronaviruses (Source: NIAD)

The Paul-Ehrlich-Institut approves another phase I clinical trial for a COVID-19 vaccine candidate in Germany. This peptide vaccine was developed by the University of Tübingen. It is another promising approach to add to the range of vaccine platforms, complementing the mRNA and vector vaccines.